Developing a European Framework for Research on Children's Medicines: An Examination of the Proposed EU Regulation on Medicinal Products for Paediatric Use
Seyberth, Hannsjörg W.
Pediatric Nephrology 2005 November; 20(11): 1537-1540
Showing items related by title, author, creator and subject.
Access to Investigational Medicinal Products for Minors in Europe: Ethical and Regulatory Issues in Negotiating Children's Access to Investigational Medicines Pinxten, Wim; Nys, Herman; Dierickx, Kris (2010-12)Patients who search for a better treatment, an increased quality of life, or even a chance to preserve life itself may claim to have an interest in accessing investigational medicinal products (IMP), particularly when no ...
Judgment of the Court of First Instance (Fifth Chamber) of 18 December 2003. Nancy Fern Olivieri v. Commission of the European Communities and European Agency for the Evaluation of Medicinal Products. Medicinal Product - Marketing Authorisation -Opinion of the European Agency for the Evaluation of Medicinal Products - Admissibility - Interest in Bringing Proceedings - Public Health - Verification of Reported Data - Review of Scientific Evaluations - Professional Reputation. Case T-326/99 Unknown author (European Union. Court of First Instance, 2003-12-18)